QuickVue Influenza A+B Clinical Field Trial
NCT00491283 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2008-01-28
Summary
A comparative study of different swab types used for collection of specimens for rapid inluenza testing
Conditions
Interventions
- DEVICE
-
Swab Specimen Collection (QuickVue)
Sponsors & Collaborators
-
Quidel Corporation
lead INDUSTRY
Principal Investigators
-
Andrew Keller, MD · Sydney Airport medical Centre
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-31
- Primary Completion
- 2006-08-31
- Completion
- 2006-08-31
Countries
- Australia
Study Locations
More Related Trials
-
FLU A+B Nasal Swab Clinical Study
NCT00636662 ·Status: COMPLETED
-
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children
NCT00192322 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test for the Rapid Identification of Influenza A/B
NCT02767414 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults
NCT02148328 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months
NCT05212623 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults
NCT00545701 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B
NCT01753531 ·Status: COMPLETED
-
Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)
NCT06417853 ·Status: COMPLETED ·Phase: PHASE1
-
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults
NCT00192192 ·Status: COMPLETED ·Phase: PHASE3
-
Ellume·Lab Flu A+B Test and the Ellume Home Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction
NCT03595358 ·Status: COMPLETED ·Phase: NA
-
Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older
NCT00217230 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trials of Quadrivalent Influenza Vaccine
NCT06824519 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine
NCT05284851 ·Status: UNKNOWN ·Phase: PHASE2
-
Human Infection Study of H3N2 Influenza in Healthy Adults
NCT06972810 ·Status: COMPLETED ·Phase: NA
-
Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test
NCT07190131 ·Status: COMPLETED
-
Study of SAB-176 in Healthy Adult Participants
NCT04850898 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Assess the Safety of a New Influenza Vaccine
NCT01104493 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults
NCT00562484 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
NCT06178991 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
NCT06683352 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines
NCT01674205 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Influenza Virus Vaccines in Children and Adults
NCT00988143 ·Status: COMPLETED ·Phase: PHASE2
-
Covid-19 and Influenza Oral Vaccine Study
NCT06355232 ·Status: RECRUITING ·Phase: PHASE1
-
Nasal Swab Home Collection Kit (NSHC Kit) Study
NCT03813966 ·Status: COMPLETED
-
An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older
NCT04806529 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3